Pharma & Healthcare

Global CD19-targeted CAR-T Cell Therapy Market Research Report 2026

This report delivers a comprehensive overview of the global CD19-targeted CAR-T Cell Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding CD19-targeted CAR-T Cell Therapy. The CD19-targeted CAR-T Cell Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global CD19-targeted CAR-T Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist CD19-targeted CAR-T Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Gilead (Yescarta&Tecartus)
Novartis (Kymriah)
Bristol-Myers Squibb (Breyanzi)
FOSUNKite (Yescarta)
Shanghai Yaoming Juno (Carteyva)
Juventas
Segment by Type
Yescarta
Kymriah
Tecartus
Others
Segment by Application
Lymphoma
Lymphocytic Leukemia
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for CD19-targeted CAR-T Cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Yescarta
1.2.3 Kymriah
1.2.4 Tecartus
1.2.5 Others
1.3 Market by Application
1.3.1 Global CD19-targeted CAR-T Cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Lymphoma
1.3.3 Lymphocytic Leukemia
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD19-targeted CAR-T Cell Therapy Market Perspective (2021–2032)
2.2 Global CD19-targeted CAR-T Cell Therapy Growth Trends by Region
2.2.1 Global CD19-targeted CAR-T Cell Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 CD19-targeted CAR-T Cell Therapy Historic Market Size by Region (2021–2026)
2.2.3 CD19-targeted CAR-T Cell Therapy Forecasted Market Size by Region (2027–2032)
2.3 CD19-targeted CAR-T Cell Therapy Market Dynamics
2.3.1 CD19-targeted CAR-T Cell Therapy Industry Trends
2.3.2 CD19-targeted CAR-T Cell Therapy Market Drivers
2.3.3 CD19-targeted CAR-T Cell Therapy Market Challenges
2.3.4 CD19-targeted CAR-T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD19-targeted CAR-T Cell Therapy Players by Revenue
3.1.1 Global Top CD19-targeted CAR-T Cell Therapy Players by Revenue (2021–2026)
3.1.2 Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top CD19-targeted CAR-T Cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by CD19-targeted CAR-T Cell Therapy Revenue
3.4 Global CD19-targeted CAR-T Cell Therapy Market Concentration Ratio
3.4.1 Global CD19-targeted CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD19-targeted CAR-T Cell Therapy Revenue in 2025
3.5 Global Key Players of CD19-targeted CAR-T Cell Therapy Head Offices and Areas Served
3.6 Global Key Players of CD19-targeted CAR-T Cell Therapy, Products and Applications
3.7 Global Key Players of CD19-targeted CAR-T Cell Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 CD19-targeted CAR-T Cell Therapy Breakdown Data by Type
4.1 Global CD19-targeted CAR-T Cell Therapy Historic Market Size by Type (2021–2026)
4.2 Global CD19-targeted CAR-T Cell Therapy Forecasted Market Size by Type (2027–2032)
5 CD19-targeted CAR-T Cell Therapy Breakdown Data by Application
5.1 Global CD19-targeted CAR-T Cell Therapy Historic Market Size by Application (2021–2026)
5.2 Global CD19-targeted CAR-T Cell Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America CD19-targeted CAR-T Cell Therapy Market Size (2021–2032)
6.2 North America CD19-targeted CAR-T Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America CD19-targeted CAR-T Cell Therapy Market Size by Country (2021–2026)
6.4 North America CD19-targeted CAR-T Cell Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD19-targeted CAR-T Cell Therapy Market Size (2021–2032)
7.2 Europe CD19-targeted CAR-T Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (2021–2026)
7.4 Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Size (2021–2032)
8.2 Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CD19-targeted CAR-T Cell Therapy Market Size (2021–2032)
9.2 Latin America CD19-targeted CAR-T Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America CD19-targeted CAR-T Cell Therapy Market Size by Country (2021–2026)
9.4 Latin America CD19-targeted CAR-T Cell Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size (2021–2032)
10.2 Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead (Yescarta&Tecartus)
11.1.1 Gilead (Yescarta&Tecartus) Company Details
11.1.2 Gilead (Yescarta&Tecartus) Business Overview
11.1.3 Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Introduction
11.1.4 Gilead (Yescarta&Tecartus) Revenue in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
11.1.5 Gilead (Yescarta&Tecartus) Recent Development
11.2 Novartis (Kymriah)
11.2.1 Novartis (Kymriah) Company Details
11.2.2 Novartis (Kymriah) Business Overview
11.2.3 Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Introduction
11.2.4 Novartis (Kymriah) Revenue in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
11.2.5 Novartis (Kymriah) Recent Development
11.3 Bristol-Myers Squibb (Breyanzi)
11.3.1 Bristol-Myers Squibb (Breyanzi) Company Details
11.3.2 Bristol-Myers Squibb (Breyanzi) Business Overview
11.3.3 Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Introduction
11.3.4 Bristol-Myers Squibb (Breyanzi) Revenue in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
11.3.5 Bristol-Myers Squibb (Breyanzi) Recent Development
11.4 FOSUNKite (Yescarta)
11.4.1 FOSUNKite (Yescarta) Company Details
11.4.2 FOSUNKite (Yescarta) Business Overview
11.4.3 FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Introduction
11.4.4 FOSUNKite (Yescarta) Revenue in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
11.4.5 FOSUNKite (Yescarta) Recent Development
11.5 Shanghai Yaoming Juno (Carteyva)
11.5.1 Shanghai Yaoming Juno (Carteyva) Company Details
11.5.2 Shanghai Yaoming Juno (Carteyva) Business Overview
11.5.3 Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Introduction
11.5.4 Shanghai Yaoming Juno (Carteyva) Revenue in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
11.5.5 Shanghai Yaoming Juno (Carteyva) Recent Development
11.6 Juventas
11.6.1 Juventas Company Details
11.6.2 Juventas Business Overview
11.6.3 Juventas CD19-targeted CAR-T Cell Therapy Introduction
11.6.4 Juventas Revenue in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
11.6.5 Juventas Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Yescarta
Table 3. Key Players of Kymriah
Table 4. Key Players of Tecartus
Table 5. Key Players of Others
Table 6. Global CD19-targeted CAR-T Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global CD19-targeted CAR-T Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global CD19-targeted CAR-T Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 9. Global CD19-targeted CAR-T Cell Therapy Market Share by Region (2021–2026)
Table 10. Global CD19-targeted CAR-T Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global CD19-targeted CAR-T Cell Therapy Market Share by Region (2027–2032)
Table 12. CD19-targeted CAR-T Cell Therapy Market Trends
Table 13. CD19-targeted CAR-T Cell Therapy Market Drivers
Table 14. CD19-targeted CAR-T Cell Therapy Market Challenges
Table 15. CD19-targeted CAR-T Cell Therapy Market Restraints
Table 16. Global CD19-targeted CAR-T Cell Therapy Revenue by Players (US$ Million), 2021–2026
Table 17. Global CD19-targeted CAR-T Cell Therapy Market Share by Players (2021–2026)
Table 18. Global Top CD19-targeted CAR-T Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on CD19-targeted CAR-T Cell Therapy Revenue, 2025
Table 19. Ranking of Global Top CD19-targeted CAR-T Cell Therapy Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by CD19-targeted CAR-T Cell Therapy Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of CD19-targeted CAR-T Cell Therapy, Headquarters and Area Served
Table 22. Global Key Players of CD19-targeted CAR-T Cell Therapy, Products and Applications
Table 23. Global Key Players of CD19-targeted CAR-T Cell Therapy, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global CD19-targeted CAR-T Cell Therapy Market Size by Type (US$ Million), 2021–2026
Table 26. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Type (2021–2026)
Table 27. Global CD19-targeted CAR-T Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Type (2027–2032)
Table 29. Global CD19-targeted CAR-T Cell Therapy Market Size by Application (US$ Million), 2021–2026
Table 30. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Application (2021–2026)
Table 31. Global CD19-targeted CAR-T Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global CD19-targeted CAR-T Cell Therapy Revenue Market Share by Application (2027–2032)
Table 33. North America CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America CD19-targeted CAR-T Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 35. North America CD19-targeted CAR-T Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 36. Europe CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 38. Europe CD19-targeted CAR-T Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America CD19-targeted CAR-T Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America CD19-targeted CAR-T Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 48. Gilead (Yescarta&Tecartus) Company Details
Table 49. Gilead (Yescarta&Tecartus) Business Overview
Table 50. Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Product
Table 51. Gilead (Yescarta&Tecartus) Revenue in CD19-targeted CAR-T Cell Therapy Business (US$ Million), 2021–2026
Table 52. Gilead (Yescarta&Tecartus) Recent Development
Table 53. Novartis (Kymriah) Company Details
Table 54. Novartis (Kymriah) Business Overview
Table 55. Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Product
Table 56. Novartis (Kymriah) Revenue in CD19-targeted CAR-T Cell Therapy Business (US$ Million), 2021–2026
Table 57. Novartis (Kymriah) Recent Development
Table 58. Bristol-Myers Squibb (Breyanzi) Company Details
Table 59. Bristol-Myers Squibb (Breyanzi) Business Overview
Table 60. Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Product
Table 61. Bristol-Myers Squibb (Breyanzi) Revenue in CD19-targeted CAR-T Cell Therapy Business (US$ Million), 2021–2026
Table 62. Bristol-Myers Squibb (Breyanzi) Recent Development
Table 63. FOSUNKite (Yescarta) Company Details
Table 64. FOSUNKite (Yescarta) Business Overview
Table 65. FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Product
Table 66. FOSUNKite (Yescarta) Revenue in CD19-targeted CAR-T Cell Therapy Business (US$ Million), 2021–2026
Table 67. FOSUNKite (Yescarta) Recent Development
Table 68. Shanghai Yaoming Juno (Carteyva) Company Details
Table 69. Shanghai Yaoming Juno (Carteyva) Business Overview
Table 70. Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Product
Table 71. Shanghai Yaoming Juno (Carteyva) Revenue in CD19-targeted CAR-T Cell Therapy Business (US$ Million), 2021–2026
Table 72. Shanghai Yaoming Juno (Carteyva) Recent Development
Table 73. Juventas Company Details
Table 74. Juventas Business Overview
Table 75. Juventas CD19-targeted CAR-T Cell Therapy Product
Table 76. Juventas Revenue in CD19-targeted CAR-T Cell Therapy Business (US$ Million), 2021–2026
Table 77. Juventas Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
Table 81. Authors List of This Report


List of Figures
Figure 1. CD19-targeted CAR-T Cell Therapy Picture
Figure 2. Global CD19-targeted CAR-T Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global CD19-targeted CAR-T Cell Therapy Market Share by Type: 2025 vs 2032
Figure 4. Yescarta Features
Figure 5. Kymriah Features
Figure 6. Tecartus Features
Figure 7. Others Features
Figure 8. Global CD19-targeted CAR-T Cell Therapy Market Size by Application (US$ Million), 2021–2032
Figure 9. Global CD19-targeted CAR-T Cell Therapy Market Share by Application: 2025 vs 2032
Figure 10. Lymphoma Case Studies
Figure 11. Lymphocytic Leukemia Case Studies
Figure 12. CD19-targeted CAR-T Cell Therapy Report Years Considered
Figure 13. Global CD19-targeted CAR-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global CD19-targeted CAR-T Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global CD19-targeted CAR-T Cell Therapy Market Share by Region: 2025 vs 2032
Figure 16. Global CD19-targeted CAR-T Cell Therapy Market Share by Players in 2025
Figure 17. Global CD19-targeted CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by CD19-targeted CAR-T Cell Therapy Revenue in 2025
Figure 19. North America CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America CD19-targeted CAR-T Cell Therapy Market Share by Country (2021–2032)
Figure 21. United States CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe CD19-targeted CAR-T Cell Therapy Market Share by Country (2021–2032)
Figure 25. Germany CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Share by Region (2021–2032)
Figure 33. China CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America CD19-targeted CAR-T Cell Therapy Market Share by Country (2021–2032)
Figure 41. Mexico CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Share by Country (2021–2032)
Figure 45. Israel CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE CD19-targeted CAR-T Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Gilead (Yescarta&Tecartus) Revenue Growth Rate in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
Figure 49. Novartis (Kymriah) Revenue Growth Rate in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
Figure 50. Bristol-Myers Squibb (Breyanzi) Revenue Growth Rate in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
Figure 51. FOSUNKite (Yescarta) Revenue Growth Rate in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
Figure 52. Shanghai Yaoming Juno (Carteyva) Revenue Growth Rate in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
Figure 53. Juventas Revenue Growth Rate in CD19-targeted CAR-T Cell Therapy Business (2021–2026)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies